Ac-225-MTI-201
225Ac-MTI-201, formerly 225Ac-DOTA-MC1RL, is a melanocortin 1 receptor ligand labeled [...]
Ac-225-FPI-2068
225Ac-FPI-2068 is a targeted alpha therapy (TAT) designed to deliver [...]
Ac-225-DOTA-YS5
225Ac-DOTA-YS5 is a CD46-targeted PET radiopharmaceutical under evaluation for therapeutic [...]
Pb-212-VMT-α-NET
212Pb-VMT-α-NET is the therapeutic analogue of the imaging agent 203Pb-VMT-α-NET [...]
Pb-212-GRPR
212Pb-GRPR (or 212Pb-DOTAM-GRPR1) is a radioimmunoconjugate comprised of ²¹²Pb, the [...]
Pb-212-ADVC001
212Pb-ADVC001 is an alpha-emitting PSMA targeting radiolabeled molecule developed in [...]
At-211-Parthanatine
211At-Parthanatine is an alpha-emitting radiopharmaceutical therapeutic that targets poly(adenosine-diphosphate-ribose) polymerase [...]
Ac-225-FPI-2265
225Ac-FPI-2265 (225Ac-PSMA-I&T) is another alpha emitter analogue of the marketed [...]
At-211-MABG
211At-MABG (211At-Meta-Astato-Benzyl-Guanidine) is a norepinephrine transporter (NET) targeting molecule, astatine-211 [...]
Ac-225-FPI-2059
225Ac-FPI-2059 (225Ac-3BP-227, 225Ac-IPN-01087) is the 225Ac-labeled analogue of 177Lu-IPN-1087, a [...]